Chart Your Course

APRIL 6, 2015

The top items on their wish list are better pay policies, clearer top-down communication, and greater transparency about pay. Pharmaceutical and biotechnology make up the second-largest group with three representatives: Genentech, Amgen and Pfizer. Costco, at No. Procter & Gamble. Union Pacific.

White Paper 100

White Paper Company Biotechnology Case Study 100

Harvard Business Review

MARCH 1, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. And biotechnology and medical devices are among the leading areas for venture capital funding. Medicare payment policy favors doing more, not doing better.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

MARCH 2, 2012

Here at Harvard Business School, Dean Nitin Nohria has revamped HBS's MBA curriculum to emphasize practical leadership and global experiences. American companies send their most promising leaders abroad for global leadership assignments. In 2011, 71% of HBS's new cases were written about foreign companies.

Competitive Advantage 12

Competitive Advantage Globalization Development Intellectual Capital 12

Harvard Business Review

JUNE 12, 2012

trillion in government support for seven "strategic emerging industries," including alternative energy, biotechnology, next-gen IT, high-end manufacturing equipment, and advanced materials. Science and engineering have become devalued amongst American students and policy-makers. It pledges $1.5 Technology belongs on that list as well.

First-mover Advantage 8

First-mover Advantage GDP Technology Biotechnology 8

Harvard Business Review

JUNE 16, 2016

In 2011, he commissioned a report that called for an “innovation policy” rather than an “industrial policy.” Other nations may challenge that leadership in one industry or another, but nobody can match the breadth and depth of the United States. a leader in virtually every area of advanced technology.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

AUGUST 23, 2016

Our limited sample suggests that both groups agree that board leadership should serve as champions of board diversity, but they differ on the policies they advocate to increase board diversity. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g.,

Politics 8

Politics Committee Telecommunications Diversity 8